Reactions Weekly

, Volume 1635, Issue 1, pp 174–174 | Cite as

Ipilimumab/pembrolizumab interaction

Hypothyroidism, hepatotoxicity and rash: case report
Case report
  • 23 Downloads

Reference

  1. Aya F, et al. Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma. Future Oncology 12: 2683-2688, No. 23, Dec 2016. Available from: URL: http://doi.org/10.2217/fon-2016-0037 - SpainCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations